USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut

Q: Where does Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut ranks #41,390 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: How is the Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 6 granted patents across 8 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Leibniz-institut ranks #41,390 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 8 technology areas.

#41,390
of 49,997 US assignees by volume: 26th percentile
by Innovation Score (28.0/100): 15.2
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R41390 · Foreign Corporation #41,390 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #41,390/49,997
PHOTO-FINISH Ledger SAS
CPC-NARROW C07D · 8 areas
INNOV-THIN 28.0/100
CLAIMS-RICH 15.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ledger SAS (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Leibniz-Institut… · this assignee

28
3D Lighting… · lowest

7

What this shows Leibniz-institut's Innovation Score is 28.0/100 (26th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Leibniz-institut's grants concentrate

Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut is a focused PatentsView assignee: 8 CPC subclasses with 66.7% of grants classified under C07D (Heterocyclic Compounds). By volume, Leibniz-institut sits between Ledger SAS and Lenz Therapeutics, Inc..

Leibniz-institut's three-year grant acceleration

Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ledger SAS

6
Legends Attractio…

6
Legionarius

6
Leibniz-institut…

6
Leishen Intellige…

6
Leman Micro Devic…

6
Lenovoemc

6
Lenz Therapeutics

6
Leibniz-institut… ◀

6

What this shows Leibniz-Institut holds 6 patents at rank #41,428, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Leibniz-Institut

By rank, the assignees closest to #41,428 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Leibniz-Institut's primary technology class.

Leibniz-institut's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 26th percentile higher than 26% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	16.7%
2018	1	16.7%
2019	1	16.7%
2020	1	16.7%
2021	1	16.7%
2022	1	16.7%

Which technologies does Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut patent most?

C07D - Heterocyclic Compounds 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

C07C - Acyclic OR Carbocyclic Compounds 1

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#41,390

of 49,997 tracked assignees

Innovation Score

28.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut's patent record in context - here's where to go next.

Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut's lead technology class is C07D (Heterocyclic Compounds), 66.7% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #41,390 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut against Ledger SAS, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.